• Gilead Sciences, Inc.
  •  Overview
  • Last Modified:
  • June 4, 2024
  • Company type:
  • Public
  • Industry:
  • Chemicals
  • Verified:
  • No
  • No of Employees:
  • 10 001 - 50 000
  • Stock Code:
  • GILD
  • Download
  • Signed Health Status Declaration Form
  • Turnover $50m + ?:
  • Yes
  • Headquarters:
  • Foster City, California, United States
  • Public Interest Score:
  • 750+

 

  • Gilead Sciences, Inc.
  • General Information

Description

Gilead Sciences is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases.

Daniel O’Day:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Jacqueline Barton:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Jeffrey Bluestone:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Sandra Horning:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Kelly Kramer:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Harish Manwani:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Javier Rodriguez:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Anthony Welters:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Ted Love:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No

Subsribe/ Login to view details on company risk rating

Subscribe / Login

 

5 Benchmark > 4 Excellent > 3  Good > 2 Caution > 1 Risk

 

  • Company Information
  • Company System Number:
  • 15155
  • Founded Year: 
  • 1987
  • Registration Number: 
  • 94-3047598
  • Country: 
  • United States of America
  • Stock Exchanges: 
    • NASDAQ Stock Exchange
  • Financial year end: 
  • December
  • No. of Countries operations: 
  • 43
  • Company Status: 
  • In Business
  • Industry Sub Category: 
  • Chemicals
  • Date listed on Stock Exchange: 
  • 01/01/1992

 

  • Contact Information
  • Business operation: 
  • Gilead Sciences is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases.
  • Primary office: 
  • 333 Lakeside Drive. Foster City, CA 94404

 

  • Additional Information
  • Listed?: 
  • Yes
  • Company secretary: 
  • Deborah H. Telman
  • Reporting currency: 
  • USD
  • ISIN number (12 digit): 
NASDAQ
US5587361A
  • Authorised shares:
  • 2 805 000 000
  • Issued shares:
  • 1 557 000 000
  • No of shareholders:
  • 1001 and more shareholders
  • No of shareholders holding 20%:
  • 0 shareholders
  • Number of shares traded
  • Per Year:
  • Per Quarter:
  • Per Month:

 

Subscribe/ Login to view more details on Health Status 

Subscribe / Login

 

Shareholders holding 5% +


For a comprehensive list, please contact InsidEntity.

Credit Rating

NameLogoCountryHeadquartersRating
Moody'sCredit LogoUnited States of AmericaNew YorkA3
S&P Global Credit LogoUnited States of AmericaNew YorkBBB+

 

Countries Operations/ Offices


 

Company Directors

Name
Nationality
Age
Role
Qualification
Name

Daniel

Executive
NationalityAmerican
61
RoleCEO
QualificationBachelor's degree in biology, MBA
Date Appointed: 19/03/2019
Duration:
6 years and 8 months
Independance: Y
Profile
Name

Jacqueline K.

Executive
NationalityAmerican
73
RoleED
QualificationBA Chemistry
Date Appointed: 01/01/2018
Duration:
7 years and 11 months
Independance: Y
Profile
Name

Jeffrey A.

Executive
NationalityAmerican
72
RoleED
QualificationB.S. in biology and M.S. in microbiolog, Ph.D. in immunology
Date Appointed: 01/12/2020
Duration:
5 years and 0 month
Independance: Y
Profile
Name

Sandra J.

Executive
NationalityAmerican
RoleED
QualificationDoctorate and an undergraduate degree
Date Appointed: 01/01/2020
Duration:
5 years and 11 months
Independance: Y
Profile
Name

Kelly A.

Executive
NationalityAmerican
RoleED
QualificationNot Available
Date Appointed: 01/08/2016
Duration:
9 years and 4 months
Independance: Y
Profile
Name

Harish

Executive
NationalityAmerican
72
RoleED
QualificationMaster's degree in management
Date Appointed: 01/05/2018
Duration:
7 years and 7 months
Independance: Y
Profile
Name

Javier

Executive
NationalityAmerican
53
RoleED
QualificationB.Fin, MBA
Date Appointed: 01/06/2020
Duration:
5 years and 6 months
Independance: Y
Profile
Name

Anthony

Executive
NationalityAmerican
69
RoleED
QualificationUndergraduate degree, graduate degree Law
Date Appointed: 01/10/2020
Duration:
5 years and 2 months
Independance: Y
Profile
Name

Ted

Non Executive
NationalityAmerican
62
RoleNED
QualificationB.A Molecular Biology, M.D
Date Appointed: 01/02/2024
Duration:
1 year and 10 months
Independance: Y
Profile

 

Directors Tenure

Name
Duration
Name

Daniel O'Day

Duration6 years and 8 months
Profile
Name

Jacqueline K. Barton

Duration7 years and 11 months
Profile
Name

Jeffrey A. Bluestone

Duration5 years and 0 month
Profile
Name

Sandra J. Horning

Duration5 years and 11 months
Profile
Name

Kelly A. Kramer

Duration9 years and 4 months
Profile
Name

Harish Manwani

Duration7 years and 7 months
Profile
Name

Javier Rodriguez

Duration5 years and 6 months
Profile
Name

Anthony Welters

Duration5 years and 2 months
Profile
Name

Ted Love

Duration1 year and 10 months
Profile

 

Director Experience

Name
Experience
Name

Daniel

Experience Chemicals, Pharmaceutical
Profile
Name

Jacqueline K.

Experience Chemicals, Education
Profile
Name

Jeffrey A.

Experience Chemicals, Healthcare, Pharmaceutical
Profile
Name

Sandra J.

Experience Chemicals, Healthcare, Pharmaceutical
Profile
Name

Kelly A.

Experience Financial Services, Technology, Healthcare
Profile
Name

Harish

Experience Investment, Other
Profile
Name

Javier

Experience Healthcare
Profile
Name

Anthony

Experience Healthcare, Pharmaceutical
Profile
Name

Ted

Experience Healthcare, Technology, Pharmaceutical
Profile

 

Company Auditors

Name
Date Appointed
Years
Name

Ernst & Young

Date Appointed01/01/1988
Year37 years and 11 months
Profile

 

Company Past Directors

Name
ED/NED
Role
Name

Kevin

ED/NEDNon Executive
RoleNED
Date Appointed: 01/01/2009
Date Resigned: 01/01/2024
Profile

 

Company Committees

Name

Daniel O'Day

Mainboard, Audit, Remuneration BD
Profile
Name

Jacqueline K. Barton

Mainboard, Audit, Remuneration BD, RE, OT
Profile
Name

Jeffrey A. Bluestone

Mainboard, Audit, Remuneration BD, OT
Profile
Name

Sandra J. Horning

Mainboard, Audit, Remuneration BD, NG, OT
Profile
Name

Kelly A. Kramer

Mainboard, Audit, Remuneration BD, AU, RE
Profile
Name

Harish Manwani

Mainboard, Audit, Remuneration BD, RE, NG
Profile
Name

Javier Rodriguez

Mainboard, Audit, Remuneration BD, AU
Profile
Name

Anthony Welters

Mainboard, Audit, Remuneration BD, RE, NG
Profile
Name

Ted Love

Mainboard, Audit, Remuneration BD, AU
Profile

 

Committee
Abbreviation
Supervisory Board
SB
Board
BD
Risk & Compliance
RC
Audit
AU
Remuneration
RE
Capital investment
CI
Industry Specific
IS
Nominations & Governance
NG
Health, Safety & Environment
HS
Social & Ethics
SE
Technology
TE
Executive
EX
Other
OT